SIA
PBYI icon

Sit Investment Associates’s Puma Biotechnology PBYI Stock Holding History

Sit Investment Associates’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-5,875
Closed -$173K – 472
2016
Q1 		$173K Hold
5,875
– – ﹤0.01% 405
2015
Q4 		$461K Hold
5,875
– – 0.01% 362
2015
Q3 		$443K Hold
5,875
– – 0.01% 374
2015
Q2 		$686K Hold
5,875
– – 0.01% 342
2015
Q1 		$1.39M Sell
5,875
-4,800
-45% -$1.03M 0.02% 276
2014
Q4 		$2.02M Sell
10,675
-55
-0.5% -$12.2K 0.03% 266
2014
Q3 		$2.56M Sell
10,730
-12,335
-53% -$2.53M 0.04% 244
2014
Q2 		$1.52M Hold
23,065
– – 0.03% 309
2014
Q1 		$2.4M Buy
23,065
+2,200
+11% +$259K 0.04% 272
2013
Q4 		$2.16M Sell
20,865
-7,000
-25% -$411K 0.04% 279
2013
Q3 		$1.5M Buy
+27,865
New +$1.5M 0.03% 303

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return